Periodic Reporting for period 3 - SilkFUSION (Genetically engineered human pluripotent stem cells, functionalized silk-fibroin platforms and bio-inks: a novel solution for large-scale ex-vivo platelet production, transfusion and drug research)

Summary
The limited supply of human platelets and the rapidly growing demand for medical research and clinical applications including studies of platelet-related disease mechanisms and platelet transfusions for patients are manifest. Therefore, in transfusion medicine, there is an...
More information & hyperlinks
Web resources: https://silkfusion.eu/